在类风湿性关节炎中,JAK-STAT信号传递和颗粒细胞-巨细胞殖民地刺激因子在骨质炎和骨微观结构变化的发展中的作用
Tsuneyasu Yoshida1,2, Yoshiki Murotani3, Koichi Murata3,4
1Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, 54 Shogoin-Kawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan.
Arthritis research & therapy
|July 10, 2025
概括
颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 通过促进骨质细胞分化,驱动早期关节炎变化,如骨炎和骨微观结构变化. 向GM-CSF可能会防止类风湿性关节炎 (RA) 的放射性进展.
科学领域:
- 风湿病学和免疫学
- 分子生物学分子生物学
- 骨生物学 骨生物学
背景情况:
- 骨质炎和骨微观结构变化 (BMC) 是类风湿性关节炎 (RA) 的早期指标,先于骨质侵蚀.
- 氏激酶 (JAK) 抑制剂,如巴里西提尼布,显示出抑制这些早期关节炎变化的潜力.
- 在RA中早期骨炎和BMC背后的精确分子机制需要进一步阐明.
研究的目的:
- 在RA的动物模型中研究驱动骨炎和BMC的分子机制.
- 探索颗粒细胞-巨细胞殖民地刺激因子 (GM-CSF) 在早期关节炎骨变化中的作用.
- 评估针对GM-CSF的治疗潜力,以预防RA的早期放射性变化.
主要方法:
- 骨质炎和骨结核被用MRI和微CT评估,用于对齐莫桑治疗的SKG小鼠.
- 分析了骨髓细胞群和JAK-STAT细胞因子表达 (包括GM-CSF).
- 小鼠接受了巴里西提尼布,抗GM-CSF抗体或复合GM-CSF (r-GM-CSF) 的治疗;在体外试验中,用于骨质细胞分化的人类单细胞和r-GM-CSF的测试.
主要成果:
- 在SKG小鼠中,骨质炎和BMC先于关节炎发作,与扩展的粒细胞-巨细胞系细胞和骨质细胞前体有关.
- 在骨髓中观察到高调的GM-CSF表达;GM-CSF在体外促进了骨质细胞分化.
- 巴里西丁尼和抗GM-CSF抗体抑制了骨质炎和BMC,而r-GM-CSF加剧了这些变化,特别是在骨质细胞分化的后期阶段.
结论:
- 转基因-CSF是早期骨炎和RA的BMC的关键驱动因素,通过增强炎症细胞群和骨质细胞生成.
- 向GM-CSF是一个有前途的治疗策略,可以缓解早期骨损伤,并防止类风湿性关节炎的放射性进展.
- 了解GM-CSF的作用为开发疾病修饰性抗风湿药物 (DMARD) 提供了新的途径.
相关概念视频
The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Osteoclasts in Bone Remodeling
3.2K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.2K
Role of Hematopoietic Growth Factors
1.7K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.7K


